Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9539 |
High Similarity |
NPD7298 |
Approved |
0.859 |
High Similarity |
NPD4584 |
Approved |
0.8562 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.8385 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD8053 |
Approved |
0.8372 |
Intermediate Similarity |
NPD8054 |
Approved |
0.8313 |
Intermediate Similarity |
NPD6107 |
Approved |
0.8263 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD6031 |
Approved |
0.825 |
Intermediate Similarity |
NPD6030 |
Approved |
0.8228 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.8228 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD3639 |
Approved |
0.8137 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.8137 |
Intermediate Similarity |
NPD3641 |
Approved |
0.8077 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.8036 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7965 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7965 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7955 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7955 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7952 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7919 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD2898 |
Approved |
0.784 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7753 |
Intermediate Similarity |
NPD6618 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7746 |
Intermediate Similarity |
NPD27 |
Approved |
0.7742 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7738 |
Intermediate Similarity |
NPD2978 |
Approved |
0.773 |
Intermediate Similarity |
NPD2420 |
Approved |
0.773 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7673 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7628 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7614 |
Intermediate Similarity |
NPD5313 |
Approved |
0.761 |
Intermediate Similarity |
NPD6896 |
Approved |
0.761 |
Intermediate Similarity |
NPD6895 |
Approved |
0.76 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7598 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7598 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7598 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7598 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7593 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7586 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7586 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7582 |
Intermediate Similarity |
NPD5310 |
Approved |
0.7582 |
Intermediate Similarity |
NPD5311 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7544 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD3051 |
Approved |
0.747 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7442 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7432 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7425 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7405 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7403 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7348 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD817 |
Approved |
0.7329 |
Intermediate Similarity |
NPD5314 |
Approved |
0.7329 |
Intermediate Similarity |
NPD823 |
Approved |
0.7322 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7287 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7283 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7283 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD6612 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7219 |
Intermediate Similarity |
NPD52 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7213 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.7213 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7212 |
Intermediate Similarity |
NPD4257 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4256 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7184 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7176 |
Intermediate Similarity |
NPD4727 |
Phase 1 |
0.7173 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7169 |
Intermediate Similarity |
NPD2459 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2458 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2460 |
Phase 3 |
0.7167 |
Intermediate Similarity |
NPD5708 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7166 |
Intermediate Similarity |
NPD2488 |
Approved |
0.716 |
Intermediate Similarity |
NPD2874 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD3645 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD7034 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1132 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1130 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1136 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7093 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7085 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7083 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD597 |
Approved |
0.7081 |
Intermediate Similarity |
NPD601 |
Approved |
0.7081 |
Intermediate Similarity |
NPD598 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD3936 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD1771 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD2120 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD3531 |
Approved |
0.7037 |
Intermediate Similarity |
NPD3532 |
Approved |
0.7037 |
Intermediate Similarity |
NPD3530 |
Approved |
0.7033 |
Intermediate Similarity |
NPD4873 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7032 |
Intermediate Similarity |
NPD2667 |
Approved |
0.703 |
Intermediate Similarity |
NPD2155 |
Approved |
0.703 |
Intermediate Similarity |
NPD2156 |
Approved |
0.703 |
Intermediate Similarity |
NPD2154 |
Approved |
0.7029 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7029 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7029 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5156 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD2989 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7012 |
Intermediate Similarity |
NPD2986 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7006 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7 |
Intermediate Similarity |
NPD3635 |
Approved |
0.7 |
Intermediate Similarity |
NPD3636 |
Approved |
0.7 |
Intermediate Similarity |
NPD3637 |
Approved |
0.6995 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD824 |
Approved |
0.699 |
Remote Similarity |
NPD4040 |
Phase 1 |
0.6989 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6988
|
Remote Similarity |
NPD3156 |
Discontinued |